Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has issued an announcement.
Proteomics International Laboratories Ltd announced its participation in the Bell Potter Healthcare Conference 2025, where Dr. Richard Lipscombe will present on the company’s advancements. This engagement underscores the company’s commitment to showcasing its innovative diagnostic solutions, potentially enhancing its industry position and stakeholder engagement.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a medical technology company specializing in precision diagnostics and bio-analytical services. The company focuses on proteomics, which involves the large-scale study of protein structures and functions, aiming to enhance disease treatment through innovative diagnostic tools.
Average Trading Volume: 303,660
Technical Sentiment Signal: Sell
Current Market Cap: A$55.65M
Learn more about PIQ stock on TipRanks’ Stock Analysis page.